Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com

Europe Multiomics Market Size, Share & Industry Trends Analysis Report By Type (Bulk Multiomics, and Single-cell Multiomics), By Product & Service, By End-use, By Platform, By Application, By Country and Growth Forecast, 2023 - 2030

Published Date : 31-Oct-2023

Pages: 175

Formats: PDF

The Europe Multiomics Market would witness market growth of 14.6% CAGR during the forecast period (2023-2030).

Tumor heterogeneity, the presence of diverse cell populations within a single tumor, is a significant challenge in cancer treatment. Multiomics data integration enables the comprehensive characterization of intra-tumours heterogeneity, helping researchers understand the genomic, transcriptomic, and proteomic differences between tumor cell subpopulations. For instance, in breast cancer, multiomics analysis has revealed that tumors can exhibit significant heterogeneity in gene expression, protein profiles, and genetic mutations. This understanding has led to the development of therapies that target multiple aspects of tumor heterogeneity, increasing the likelihood of treatment success.

Personalized medicine leverages this data to tailor treatment approaches to an individual's genetic, transcriptomic, and proteomic profile, maximizing therapeutic efficacy and minimizing adverse effects. It aids in the development of crops with increased nutritional value, pest and disease resistance, and yield. In the agri-food sector, it is used for quality control, traceability, and food safety. It is crucial for optimizing bioprocesses, leading to increased production of biofuels, pharmaceuticals, and industrial enzymes. In synthetic biology, multiomics data guides the design of synthetic organisms for various purposes, including bioremediation and biosensors.

The adoption of multiomics approaches has steadily increased across various domains, driven by the need for more comprehensive and data-rich insights into complex biological systems. Developing high-throughput sequencing, mass spectrometry, and other omics technologies has made it cost-effective and feasible to generate large-scale multiomics datasets. Increasing computational power and developing sophisticated bioinformatics tools enable the storage, analysis, and interpretation of multiomics data on a previously unimaginable scale. The proliferation of open-access biological databases facilitates the collection, storage, and retrieval of multiomics data, making it a valuable resource for researchers.

As per the data provided by the International Trade Administration, the Italian biotech industry is expanding, with a revenue of $12.3 billion in 2020. The majority of businesses, 376 out of 777, or 48%, are in the red biotech (life sciences) category. Pharmaceutical and medical device biotech businesses contribute 74% of the turnover with expanded research in diagnosis and cutting-edge therapies. There are over 200 cutting-edge start-ups, as well as roughly 100 public research institutions, university labs, and 47 scientific and research hospitals (IRCCS). Therefore, increased investment in the biotech industry in Europe will help in the expansion of the market in the region.

The Germany market dominated the Europe Multiomics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $370.5 million by 2030. The UK market is exhibiting a CAGR of 13.6% during (2023 - 2030). Additionally, The France market would experience a CAGR of 15.4% during (2023 - 2030).

Based on Type, the market is segmented into Bulk Multiomics, and Single-cell Multiomics. Based on Product & Service, the market is segmented into Product (Instruments, Consumables, and Software), and Services. Based on End-use, the market is segmented into Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others. Based on Platform, the market is segmented into Genomics, Transcriptomics, Proteomics, Metabolomics, and Integrated Omics Platforms. Based on Application, the market is segmented into Cell Biology, Oncology, Neurology, and Immunology. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Multiomics Market will Hit $5.7 Billion by 2030, at a CAGR of 15%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc, Illumina, Inc., Danaher Corporation, PerkinElmer, Inc., Bruker Corporation, Qiagen N.V., Agilent Technologies, Inc., BGI Group, Becton, Dickinson, and Company, Shimadzu Corporation.

Scope of the Study

Market Segments Covered in the Report:

By Type

  • Bulk Multiomics
  • Single-cell Multiomics

By Product & Service

  • Product
    • Instruments
    • Consumables
    • Software
  • Services

By End-use

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Others

By Platform

  • Genomics
  • Transcriptomics
  • Proteomics
  • Metabolomics
  • Integrated Omics Platforms

By Application

  • Cell Biology
  • Oncology
  • Neurology
  • Immunology

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

  • Thermo Fisher Scientific, Inc
  • Illumina, Inc.
  • Danaher Corporation
  • PerkinElmer, Inc.
  • Bruker Corporation
  • Qiagen N.V.
  • Agilent Technologies, Inc.
  • BGI Group
  • Becton, Dickinson, and Company
  • Shimadzu Corporation
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Multiomics Market, by Type
1.4.2 Europe Multiomics Market, by Product & Service
1.4.3 Europe Multiomics Market, by End-use
1.4.4 Europe Multiomics Market, by Platform
1.4.5 Europe Multiomics Market, by Application
1.4.6 Europe Multiomics Market, by Country
1.5 Methodology for the research

Chapter 2. Market At a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints

Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Geographical Expansions
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2021, Jun – 2023, Mar) Leading Players
4.4 Porter’s Five Force Analysis

Chapter 5. Europe Multiomics Market by Type
5.1 Europe Bulk Multiomics Market by Country
5.2 Europe Single-cell Multiomics Market by Country

Chapter 6. Europe Multiomics Market by Product & Service
6.1 Europe Product Market by Country
6.2 Europe Multiomics Market by Product Type
6.2.1 Europe Instruments Market by Country
6.2.2 Europe Consumables Market by Country
6.2.3 Europe Software Market by Country
6.3 Europe Services Market by Country

Chapter 7. Europe Multiomics Market by End-use
7.1 Europe Academic & Research Institutes Market by Country
7.2 Europe Pharmaceutical & Biotechnology Companies Market by Country
7.3 Europe Others Market by Country

Chapter 8. Europe Multiomics Market by Platform
8.1 Europe Genomics Market by Country
8.2 Europe Transcriptomics Market by Country
8.3 Europe Proteomics Market by Country
8.4 Europe Metabolomics Market by Country
8.5 Europe Integrated Omics Platforms Market by Country

Chapter 9. Europe Multiomics Market by Application
9.1 Europe Cell Biology Market by Country
9.2 Europe Oncology Market by Country
9.3 Europe Neurology Market by Country
9.4 Europe Immunology Market by Country

Chapter 10. Europe Multiomics Market by Country
10.1 Germany Multiomics Market
10.1.1 Germany Multiomics Market by Type
10.1.2 Germany Multiomics Market by Product & Service
10.1.2.1 Germany Multiomics Market by Product Type
10.1.3 Germany Multiomics Market by End-use
10.1.4 Germany Multiomics Market by Platform
10.1.5 Germany Multiomics Market by Application
10.2 UK Multiomics Market
10.2.1 UK Multiomics Market by Type
10.2.2 UK Multiomics Market by Product & Service
10.2.2.1 UK Multiomics Market by Product Type
10.2.3 UK Multiomics Market by End-use
10.2.4 UK Multiomics Market by Platform
10.2.5 UK Multiomics Market by Application
10.3 France Multiomics Market
10.3.1 France Multiomics Market by Type
10.3.2 France Multiomics Market by Product & Service
10.3.2.1 France Multiomics Market by Product Type
10.3.3 France Multiomics Market by End-use
10.3.4 France Multiomics Market by Platform
10.3.5 France Multiomics Market by Application
10.4 Russia Multiomics Market
10.4.1 Russia Multiomics Market by Type
10.4.2 Russia Multiomics Market by Product & Service
10.4.2.1 Russia Multiomics Market by Product Type
10.4.3 Russia Multiomics Market by End-use
10.4.4 Russia Multiomics Market by Platform
10.4.5 Russia Multiomics Market by Application
10.5 Spain Multiomics Market
10.5.1 Spain Multiomics Market by Type
10.5.2 Spain Multiomics Market by Product & Service
10.5.2.1 Spain Multiomics Market by Product Type
10.5.3 Spain Multiomics Market by End-use
10.5.4 Spain Multiomics Market by Platform
10.5.5 Spain Multiomics Market by Application
10.6 Italy Multiomics Market
10.6.1 Italy Multiomics Market by Type
10.6.2 Italy Multiomics Market by Product & Service
10.6.2.1 Italy Multiomics Market by Product Type
10.6.3 Italy Multiomics Market by End-use
10.6.4 Italy Multiomics Market by Platform
10.6.5 Italy Multiomics Market by Application
10.7 Rest of Europe Multiomics Market
10.7.1 Rest of Europe Multiomics Market by Type
10.7.2 Rest of Europe Multiomics Market by Product & Service
10.7.2.1 Rest of Europe Multiomics Market by Product Type
10.7.3 Rest of Europe Multiomics Market by End-use
10.7.4 Rest of Europe Multiomics Market by Platform
10.7.5 Rest of Europe Multiomics Market by Application

Chapter 11. Company Profiles
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Segmental and Regional Analysis
11.1.4 Research & Development Expenses
11.1.5 SWOT Analysis
11.2 Illumina, Inc.
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Segmental and Regional Analysis
11.2.4 Research & Development Expense
11.2.5 Recent strategies and developments:
11.2.5.1 Partnerships, Collaborations, and Agreements:
11.2.5.2 Product Launches and Product Expansions:
11.2.5.3 Acquisition and Mergers:
11.2.5.4 Geographical Expansions:
11.2.6 SWOT Analysis
11.3 Danaher Corporation
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Segmental and Regional Analysis
11.3.4 Research & Development Expense
11.3.5 SWOT Analysis
11.4 PerkinElmer, Inc.
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Segmental and Regional Analysis
11.4.4 Research & Development Expense
11.4.5 SWOT Analysis
11.5 Bruker Corporation
11.5.1 Company Overview
11.5.2 Financial Analysis
11.5.3 Segmental and Regional Analysis
11.5.4 Research & Development Expense
11.5.5 Recent strategies and developments:
11.5.5.1 Partnerships, Collaborations, and Agreements:
11.5.5.2 Product Launches and Product Expansions:
11.5.5.3 Acquisition and Mergers:
11.5.6 SWOT Analysis
11.6 Qiagen N.V.
11.6.1 Company Overview
11.6.2 Financial Analysis
11.6.3 Regional Analysis
11.6.4 Research & Development Expense
11.6.5 SWOT Analysis
11.7 Agilent Technologies, Inc.
11.7.1 Company Overview
11.7.2 Financial Analysis
11.7.3 Segmental and Regional Analysis
11.7.4 Research & Development Expense
11.7.5 Recent strategies and developments:
11.7.5.1 Partnerships, Collaborations, and Agreements:
11.7.6 SWOT Analysis
11.8 BGI Group
11.8.1 Company Overview
11.8.2 Recent strategies and developments:
11.8.2.1 Partnerships, Collaborations, and Agreements:
11.8.3 SWOT Analysis
11.9 Becton, Dickinson, and Company
11.9.1 Company Overview
11.9.2 Financial Analysis
11.9.3 Segmental and Regional Analysis
11.9.4 Research & Development Expense
11.9.4.1 Product Launches and Product Expansions:
11.9.5 SWOT Analysis
11.10. Shimadzu Corporation
11.10.1 Company Overview
11.10.2 Financial Analysis
11.10.3 Segmental and Regional Analysis
11.10.4 Research & Development Expense
11.10.5 SWOT Analysis
TABLE 1 Europe Multiomics Market, 2019 - 2022, USD Million
TABLE 2 Europe Multiomics Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Multiomics Market
TABLE 4 Product Launches And Product Expansions– Multiomics Market
TABLE 5 Acquisition and Mergers– Multiomics Market
TABLE 6 Geographical Expansions– Multiomics Market
TABLE 7 Europe Multiomics Market by Type, 2019 - 2022, USD Million
TABLE 8 Europe Multiomics Market by Type, 2023 - 2030, USD Million
TABLE 9 Europe Bulk Multiomics Market by Country, 2019 - 2022, USD Million
TABLE 10 Europe Bulk Multiomics Market by Country, 2023 - 2030, USD Million
TABLE 11 Europe Single-cell Multiomics Market by Country, 2019 - 2022, USD Million
TABLE 12 Europe Single-cell Multiomics Market by Country, 2023 - 2030, USD Million
TABLE 13 Europe Multiomics Market by Product & Service, 2019 - 2022, USD Million
TABLE 14 Europe Multiomics Market by Product & Service, 2023 - 2030, USD Million
TABLE 15 Europe Product Market by Country, 2019 - 2022, USD Million
TABLE 16 Europe Product Market by Country, 2023 - 2030, USD Million
TABLE 17 Europe Multiomics Market by Product Type, 2019 - 2022, USD Million
TABLE 18 Europe Multiomics Market by Product Type, 2023 - 2030, USD Million
TABLE 19 Europe Instruments Market by Country, 2019 - 2022, USD Million
TABLE 20 Europe Instruments Market by Country, 2023 - 2030, USD Million
TABLE 21 Europe Consumables Market by Country, 2019 - 2022, USD Million
TABLE 22 Europe Consumables Market by Country, 2023 - 2030, USD Million
TABLE 23 Europe Software Market by Country, 2019 - 2022, USD Million
TABLE 24 Europe Software Market by Country, 2023 - 2030, USD Million
TABLE 25 Europe Services Market by Country, 2019 - 2022, USD Million
TABLE 26 Europe Services Market by Country, 2023 - 2030, USD Million
TABLE 27 Europe Multiomics Market by End-use, 2019 - 2022, USD Million
TABLE 28 Europe Multiomics Market by End-use, 2023 - 2030, USD Million
TABLE 29 Europe Academic & Research Institutes Market by Country, 2019 - 2022, USD Million
TABLE 30 Europe Academic & Research Institutes Market by Country, 2023 - 2030, USD Million
TABLE 31 Europe Pharmaceutical & Biotechnology Companies Market by Country, 2019 - 2022, USD Million
TABLE 32 Europe Pharmaceutical & Biotechnology Companies Market by Country, 2023 - 2030, USD Million
TABLE 33 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 34 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 35 Europe Multiomics Market by Platform, 2019 - 2022, USD Million
TABLE 36 Europe Multiomics Market by Platform, 2023 - 2030, USD Million
TABLE 37 Europe Genomics Market by Country, 2019 - 2022, USD Million
TABLE 38 Europe Genomics Market by Country, 2023 - 2030, USD Million
TABLE 39 Europe Transcriptomics Market by Country, 2019 - 2022, USD Million
TABLE 40 Europe Transcriptomics Market by Country, 2023 - 2030, USD Million
TABLE 41 Europe Proteomics Market by Country, 2019 - 2022, USD Million
TABLE 42 Europe Proteomics Market by Country, 2023 - 2030, USD Million
TABLE 43 Europe Metabolomics Market by Country, 2019 - 2022, USD Million
TABLE 44 Europe Metabolomics Market by Country, 2023 - 2030, USD Million
TABLE 45 Europe Integrated Omics Platforms Market by Country, 2019 - 2022, USD Million
TABLE 46 Europe Integrated Omics Platforms Market by Country, 2023 - 2030, USD Million
TABLE 47 Europe Multiomics Market by Application, 2019 - 2022, USD Million
TABLE 48 Europe Multiomics Market by Application, 2023 - 2030, USD Million
TABLE 49 Europe Cell Biology Market by Country, 2019 - 2022, USD Million
TABLE 50 Europe Cell Biology Market by Country, 2023 - 2030, USD Million
TABLE 51 Europe Oncology Market by Country, 2019 - 2022, USD Million
TABLE 52 Europe Oncology Market by Country, 2023 - 2030, USD Million
TABLE 53 Europe Neurology Market by Country, 2019 - 2022, USD Million
TABLE 54 Europe Neurology Market by Country, 2023 - 2030, USD Million
TABLE 55 Europe Immunology Market by Country, 2019 - 2022, USD Million
TABLE 56 Europe Immunology Market by Country, 2023 - 2030, USD Million
TABLE 57 Europe Multiomics Market by Country, 2019 - 2022, USD Million
TABLE 58 Europe Multiomics Market by Country, 2023 - 2030, USD Million
TABLE 59 Germany Multiomics Market, 2019 - 2022, USD Million
TABLE 60 Germany Multiomics Market, 2023 - 2030, USD Million
TABLE 61 Germany Multiomics Market by Type, 2019 - 2022, USD Million
TABLE 62 Germany Multiomics Market by Type, 2023 - 2030, USD Million
TABLE 63 Germany Multiomics Market by Product & Service, 2019 - 2022, USD Million
TABLE 64 Germany Multiomics Market by Product & Service, 2023 - 2030, USD Million
TABLE 65 Germany Multiomics Market by Product Type, 2019 - 2022, USD Million
TABLE 66 Germany Multiomics Market by Product Type, 2023 - 2030, USD Million
TABLE 67 Germany Multiomics Market by End-use, 2019 - 2022, USD Million
TABLE 68 Germany Multiomics Market by End-use, 2023 - 2030, USD Million
TABLE 69 Germany Multiomics Market by Platform, 2019 - 2022, USD Million
TABLE 70 Germany Multiomics Market by Platform, 2023 - 2030, USD Million
TABLE 71 Germany Multiomics Market by Application, 2019 - 2022, USD Million
TABLE 72 Germany Multiomics Market by Application, 2023 - 2030, USD Million
TABLE 73 UK Multiomics Market, 2019 - 2022, USD Million
TABLE 74 UK Multiomics Market, 2023 - 2030, USD Million
TABLE 75 UK Multiomics Market by Type, 2019 - 2022, USD Million
TABLE 76 UK Multiomics Market by Type, 2023 - 2030, USD Million
TABLE 77 UK Multiomics Market by Product & Service, 2019 - 2022, USD Million
TABLE 78 UK Multiomics Market by Product & Service, 2023 - 2030, USD Million
TABLE 79 UK Multiomics Market by Product Type, 2019 - 2022, USD Million
TABLE 80 UK Multiomics Market by Product Type, 2023 - 2030, USD Million
TABLE 81 UK Multiomics Market by End-use, 2019 - 2022, USD Million
TABLE 82 UK Multiomics Market by End-use, 2023 - 2030, USD Million
TABLE 83 UK Multiomics Market by Platform, 2019 - 2022, USD Million
TABLE 84 UK Multiomics Market by Platform, 2023 - 2030, USD Million
TABLE 85 UK Multiomics Market by Application, 2019 - 2022, USD Million
TABLE 86 UK Multiomics Market by Application, 2023 - 2030, USD Million
TABLE 87 France Multiomics Market, 2019 - 2022, USD Million
TABLE 88 France Multiomics Market, 2023 - 2030, USD Million
TABLE 89 France Multiomics Market by Type, 2019 - 2022, USD Million
TABLE 90 France Multiomics Market by Type, 2023 - 2030, USD Million
TABLE 91 France Multiomics Market by Product & Service, 2019 - 2022, USD Million
TABLE 92 France Multiomics Market by Product & Service, 2023 - 2030, USD Million
TABLE 93 France Multiomics Market by Product Type, 2019 - 2022, USD Million
TABLE 94 France Multiomics Market by Product Type, 2023 - 2030, USD Million
TABLE 95 France Multiomics Market by End-use, 2019 - 2022, USD Million
TABLE 96 France Multiomics Market by End-use, 2023 - 2030, USD Million
TABLE 97 France Multiomics Market by Platform, 2019 - 2022, USD Million
TABLE 98 France Multiomics Market by Platform, 2023 - 2030, USD Million
TABLE 99 France Multiomics Market by Application, 2019 - 2022, USD Million
TABLE 100 France Multiomics Market by Application, 2023 - 2030, USD Million
TABLE 101 Russia Multiomics Market, 2019 - 2022, USD Million
TABLE 102 Russia Multiomics Market, 2023 - 2030, USD Million
TABLE 103 Russia Multiomics Market by Type, 2019 - 2022, USD Million
TABLE 104 Russia Multiomics Market by Type, 2023 - 2030, USD Million
TABLE 105 Russia Multiomics Market by Product & Service, 2019 - 2022, USD Million
TABLE 106 Russia Multiomics Market by Product & Service, 2023 - 2030, USD Million
TABLE 107 Russia Multiomics Market by Product Type, 2019 - 2022, USD Million
TABLE 108 Russia Multiomics Market by Product Type, 2023 - 2030, USD Million
TABLE 109 Russia Multiomics Market by End-use, 2019 - 2022, USD Million
TABLE 110 Russia Multiomics Market by End-use, 2023 - 2030, USD Million
TABLE 111 Russia Multiomics Market by Platform, 2019 - 2022, USD Million
TABLE 112 Russia Multiomics Market by Platform, 2023 - 2030, USD Million
TABLE 113 Russia Multiomics Market by Application, 2019 - 2022, USD Million
TABLE 114 Russia Multiomics Market by Application, 2023 - 2030, USD Million
TABLE 115 Spain Multiomics Market, 2019 - 2022, USD Million
TABLE 116 Spain Multiomics Market, 2023 - 2030, USD Million
TABLE 117 Spain Multiomics Market by Type, 2019 - 2022, USD Million
TABLE 118 Spain Multiomics Market by Type, 2023 - 2030, USD Million
TABLE 119 Spain Multiomics Market by Product & Service, 2019 - 2022, USD Million
TABLE 120 Spain Multiomics Market by Product & Service, 2023 - 2030, USD Million
TABLE 121 Spain Multiomics Market by Product Type, 2019 - 2022, USD Million
TABLE 122 Spain Multiomics Market by Product Type, 2023 - 2030, USD Million
TABLE 123 Spain Multiomics Market by End-use, 2019 - 2022, USD Million
TABLE 124 Spain Multiomics Market by End-use, 2023 - 2030, USD Million
TABLE 125 Spain Multiomics Market by Platform, 2019 - 2022, USD Million
TABLE 126 Spain Multiomics Market by Platform, 2023 - 2030, USD Million
TABLE 127 Spain Multiomics Market by Application, 2019 - 2022, USD Million
TABLE 128 Spain Multiomics Market by Application, 2023 - 2030, USD Million
TABLE 129 Italy Multiomics Market, 2019 - 2022, USD Million
TABLE 130 Italy Multiomics Market, 2023 - 2030, USD Million
TABLE 131 Italy Multiomics Market by Type, 2019 - 2022, USD Million
TABLE 132 Italy Multiomics Market by Type, 2023 - 2030, USD Million
TABLE 133 Italy Multiomics Market by Product & Service, 2019 - 2022, USD Million
TABLE 134 Italy Multiomics Market by Product & Service, 2023 - 2030, USD Million
TABLE 135 Italy Multiomics Market by Product Type, 2019 - 2022, USD Million
TABLE 136 Italy Multiomics Market by Product Type, 2023 - 2030, USD Million
TABLE 137 Italy Multiomics Market by End-use, 2019 - 2022, USD Million
TABLE 138 Italy Multiomics Market by End-use, 2023 - 2030, USD Million
TABLE 139 Italy Multiomics Market by Platform, 2019 - 2022, USD Million
TABLE 140 Italy Multiomics Market by Platform, 2023 - 2030, USD Million
TABLE 141 Italy Multiomics Market by Application, 2019 - 2022, USD Million
TABLE 142 Italy Multiomics Market by Application, 2023 - 2030, USD Million
TABLE 143 Rest of Europe Multiomics Market, 2019 - 2022, USD Million
TABLE 144 Rest of Europe Multiomics Market, 2023 - 2030, USD Million
TABLE 145 Rest of Europe Multiomics Market by Type, 2019 - 2022, USD Million
TABLE 146 Rest of Europe Multiomics Market by Type, 2023 - 2030, USD Million
TABLE 147 Rest of Europe Multiomics Market by Product & Service, 2019 - 2022, USD Million
TABLE 148 Rest of Europe Multiomics Market by Product & Service, 2023 - 2030, USD Million
TABLE 149 Rest of Europe Multiomics Market by Product Type, 2019 - 2022, USD Million
TABLE 150 Rest of Europe Multiomics Market by Product Type, 2023 - 2030, USD Million
TABLE 151 Rest of Europe Multiomics Market by End-use, 2019 - 2022, USD Million
TABLE 152 Rest of Europe Multiomics Market by End-use, 2023 - 2030, USD Million
TABLE 153 Rest of Europe Multiomics Market by Platform, 2019 - 2022, USD Million
TABLE 154 Rest of Europe Multiomics Market by Platform, 2023 - 2030, USD Million
TABLE 155 Rest of Europe Multiomics Market by Application, 2019 - 2022, USD Million
TABLE 156 Rest of Europe Multiomics Market by Application, 2023 - 2030, USD Million
TABLE 157 Key Information – Thermo Fisher Scientific, Inc.
TABLE 158 key information – Illumina, Inc.
TABLE 159 Key Information – Danaher Corporation
TABLE 160 key Information – PerkinElmer, Inc.
TABLE 161 Key Information – Bruker Corporation
TABLE 162 Key Information – Qiagen N.V.
TABLE 163 key Information – Agilent Technologies, Inc.
TABLE 164 Key Information – BGI Group
TABLE 165 Key Information – Becton, Dickinson and Company
TABLE 166 Key Information – Shimadzu Corporation

List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Multiomics Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting the Multiomics Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 6 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2021, Jun – 2023, Mar) Leading Players
FIG 7 Porter’s Five Force Analysis: Multiomics Market
FIG 8 Europe Multiomics Market Share by Type, 2022
FIG 9 Europe Multiomics Market Share by Type, 2030
FIG 10 Europe Multiomics Market by Type, 2019 - 2030, USD Million
FIG 11 Europe Multiomics Market Share by Product & Service, 2022
FIG 12 Europe Multiomics Market Share by Product & Service, 2030
FIG 13 Europe Multiomics Market by Product & Service, 2019 - 2030, USD Million
FIG 14 Europe Multiomics Market Share by End-use, 2022
FIG 15 Europe Multiomics Market Share by End-use, 2030
FIG 16 Europe Multiomics Market by End-use, 2019 - 2030, USD Million
FIG 17 Europe Multiomics Market Share by Platform, 2022
FIG 18 Europe Multiomics Market Share by Platform, 2030
FIG 19 Europe Multiomics Market by Platform, 2019 - 2030, USD Million
FIG 20 Europe Multiomics Market Share by Application, 2022
FIG 21 Europe Multiomics Market Share by Application, 2030
FIG 22 Europe Multiomics Market by Application, 2019 - 2030, USD Million
FIG 23 Europe Multiomics Market Share by Country, 2022
FIG 24 Europe Multiomics Market Share by Country, 2030
FIG 25 Europe Multiomics Market by Country, 2019 - 2030, USD Million
FIG 26 Swot Analysis: Thermo Fisher Scientific, Inc.
FIG 27 Recent strategies and developments: Illumina, Inc.
FIG 28 Swot Analysis: Illumina, Inc.
FIG 29 SWOT Analysis: Danaher Corporation
FIG 30 Swot Analysis: PerkinElmer, Inc.
FIG 31 Recent strategies and developments: Bruker Corporation
FIG 32 Swot Analysis: Bruker Corporation
FIG 33 Swot Analysis: Qiagen N.V.
FIG 34 Swot Analysis: Agilent Technologies, Inc.
FIG 35 Swot Analysis: BGI Group
FIG 36 SWOT Analysis: Becton, Dickinson and company
FIG 37 Swot Analysis: Shimadzu Corporation

Purchase Full Report of
Europe Multiomics Market

Buy Now

Avail up to 60% discount on subscription plans on

SUBSCRIPTION MODEL